BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 6223626)

  • 21. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME; Kinoshita T; Nussenzweig V
    J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The region Ser333-Arg356 of the alpha-chain of human C4b-binding protein is involved in the binding of complement C4b.
    Hessing M; Kanters D; Takeya H; van 't Veer C; Hackeng TM; Iwanaga S; Bouma BN
    FEBS Lett; 1993 Feb; 317(3):228-32. PubMed ID: 8425609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function studies on human C4b-binding protein using monoclonal antibodies.
    Hessing M; Kanters D; Heijnen HF; Hackeng TM; Sixma JJ; Bouma BN
    Eur J Immunol; 1991 Sep; 21(9):2077-85. PubMed ID: 1716211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
    Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
    J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.
    Villiers MB; Thielens NM; Reboul A; Colomb MG
    Biochim Biophys Acta; 1982 Jun; 704(2):197-203. PubMed ID: 6980671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The localization of heparin-binding fragments on human C4b-binding protein.
    Hessing M; Vlooswijk RA; Hackeng TM; Kanters D; Bouma BN
    J Immunol; 1990 Jan; 144(1):204-8. PubMed ID: 2136880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.
    Blom AM; Villoutreix BO; Dahlbäck B
    J Biol Chem; 2003 Oct; 278(44):43437-42. PubMed ID: 12893820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein S binding in relation to the subunit composition of human C4b-binding protein.
    Hillarp A; Hessing M; Dahlbäck B
    FEBS Lett; 1989 Dec; 259(1):53-6. PubMed ID: 2532155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins.
    Blom AM; Berggârd K; Webb JH; Lindahl G; Villoutreix BO; Dahlbäck B
    J Immunol; 2000 May; 164(10):5328-36. PubMed ID: 10799895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human factor H and C4b-binding protein serve as factor I-cofactors both encompassing inactivation of C3b and C4b.
    Seya T; Nakamura K; Masaki T; Ichihara-Itoh C; Matsumoto M; Nagasawa S
    Mol Immunol; 1995 Apr; 32(5):355-60. PubMed ID: 7739573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM; Colomb MG
    Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal anti-human C4b antibodies: stabilization and inhibition of the classical-pathway C3 convertase.
    Ichihara C; Nakamura T; Nagasawa S; Koyama J
    Mol Immunol; 1986 Feb; 23(2):151-7. PubMed ID: 2422544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.
    Seya T; Nagasawa S; Atkinson JP
    J Immunol; 1990 Mar; 144(6):2312-20. PubMed ID: 1690242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I; Sorvillo J; Halbwachs-Mecarelli L
    J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H.
    Blom AM; Kask L; Ramesh B; Hillarp A
    Arch Biochem Biophys; 2003 Oct; 418(2):108-18. PubMed ID: 14522582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2.
    Nordström T; Blom AM; Forsgren A; Riesbeck K
    J Immunol; 2004 Oct; 173(7):4598-606. PubMed ID: 15383594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance.
    He X; Shen L; Malmborg AC; Smith KJ; Dahlback B; Linse S
    Biochemistry; 1997 Mar; 36(12):3745-54. PubMed ID: 9132028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and characterization of a recombinant C4b-binding protein lacking the beta-chain.
    Härdig Y; García de Frutos P; Dahlbäck B
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):795-800. PubMed ID: 8948435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.